Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-11 Sale |
2024-06-11 9:02 pm |
Deciphera Pharmaceuticals Inc. | Sherman Matthew L EVP & Chief Medical Officer |
72,029 | $0 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Sale |
2024-06-11 8:56 pm |
Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer |
72,029 | $0 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Sale |
2024-06-11 8:51 pm |
Deciphera Pharmaceuticals Inc. | Pitman Jama SVP, Chief Development Officer |
53,951 | $0 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Sale |
2024-06-11 8:45 pm |
Deciphera Pharmaceuticals Inc. | Dhanak Dashyant EVP & Chief Scientific Officer |
184,088 | $0 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Sale |
2024-06-11 8:39 pm |
Deciphera Pharmaceuticals Inc. | Martin Daniel C. Chief Commercial Officer |
43,951 | $0 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Sale |
2024-06-11 8:31 pm |
Deciphera Pharmaceuticals Inc. | Hoerter Steven L. President and CEO |
286,075 | $0 | $0 | 0 (Direct) |
View | |
| 2024-02-16 Sale |
2024-02-20 4:06 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,615 | $15.62 | $40,840 | 177,839 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
3,010 | $15.62 | $47,009 | 149,450 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer |
2,267 | $15.62 | $35,405 | 106,931 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
2,267 | $15.62 | $35,405 | 94,018 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:15 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,435 | $14.47 | $35,234 | 94,079 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:15 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer |
1,624 | $14.47 | $23,499 | 50,573 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:15 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
2,435 | $14.47 | $35,234 | 66,085 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:15 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,624 | $14.47 | $23,499 | 47,660 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
30,664 | $15.37 | $471,217 | 72,763 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
2,792 | $15.37 | $42,905 | 68,520 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,662 | $15.37 | $25,540 | 52,197 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,727 | $15.37 | $26,539 | 49,284 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-14 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,792 | $15.37 | $42,905 | 96,514 (Direct) |
View |
| 2023-11-30 Sale |
2023-12-01 4:05 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
17,801 | $12.57 | $223,755 | 45,435 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 4:11 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,360 | $12.02 | $28,362 | 90,628 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 4:10 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,407 | $12.02 | $16,909 | 48,283 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 4:10 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,407 | $12.02 | $16,909 | 62,884 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 4:09 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
2,316 | $12.02 | $27,833 | 63,068 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Equity Swap |
2024-06-11 9:02 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Sherman Matthew L EVP & Chief Medical Officer |
72,261 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 9:02 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Sherman Matthew L EVP & Chief Medical Officer |
34,157 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:56 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer |
42,478 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 8:56 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Kelly Thomas Patrick Chief Financial Officer |
34,157 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:51 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Pitman Jama SVP, Chief Development Officer |
34,243 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 8:51 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Pitman Jama SVP, Chief Development Officer |
20,163 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:49 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Friedman Franklin Stuart Director |
10,000 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 8:45 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Dhanak Dashyant EVP & Chief Scientific Officer |
25,913 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:39 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Martin Daniel C. Chief Commercial Officer |
31,330 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 8:39 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Martin Daniel C. Chief Commercial Officer |
20,163 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:39 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Walsh Dennis Leo Director |
11,000 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Equity Swap |
2024-06-11 8:31 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Hoerter Steven L. President and CEO |
72,763 | $0 | 0 (Direct) |
View | |
| 2024-06-11 Option Award |
2024-06-11 8:31 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | Hoerter Steven L. President and CEO |
286,075 | $0 | 0 (Direct) |
View | |
| 2024-04-22 Exercise |
2024-04-24 4:30 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
48,136 | $0.01 | 23,107,844 (Direct) |
View |
| 2024-04-22 Exercise |
2024-04-24 4:30 pm |
2022-04-28 N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
48,136 | $0 | 23,107,844 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:06 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
86,375 | $0 | 177,839 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:05 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
86,375 | $0 | 149,450 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:05 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer |
58,625 | $0 | 106,931 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:05 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
298,100 | $0 | 298,100 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:05 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Dhanak Dashyant EVP & Chief Scientific Officer |
86,375 | $0 | 227,275 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 4:05 pm |
N/A 2034-02-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
48,625 | $0 | 94,018 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 4:30 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
914,001 | $0.01 | 23,107,844 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 4:30 pm |
2022-04-28 N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
914,001 | $0 | 23,107,844 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 4:15 pm |
N/A 2034-01-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
4,727 | $10.58 | 4,727 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 4:15 pm |
N/A 2034-01-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
4,727 | $10.58 | 4,727 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 4:15 pm |
N/A 2034-01-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
4,727 | $10.58 | 4,727 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 4:15 pm |
N/A 2034-01-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
4,727 | $10.58 | 4,727 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 4:05 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
62,500 | $0 | 72,763 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 4:05 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
8,244 | $0 | 68,520 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 4:05 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
5,576 | $0 | 52,197 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 4:05 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
5,576 | $0 | 49,284 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 4:05 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
8,244 | $0 | 96,514 (Direct) |
View |
| 2023-10-28 Option Award |
2023-10-31 4:11 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
8,244 | $0 | 90,628 (Direct) |
View |
| 2023-10-28 Option Award |
2023-10-31 4:10 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
5,576 | $0 | 48,283 (Direct) |
View |
| 2023-10-28 Option Award |
2023-10-31 4:10 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
5,576 | $0 | 62,884 (Direct) |
View |
| 2023-10-28 Option Award |
2023-10-31 4:09 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
8,244 | $0 | 63,068 (Direct) |
View |